Moderate

Chronic gastroparesis — long-term management

Gastroparesis · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Delayed gastric emptying without mechanical obstruction, causing early satiety, nausea, vomiting and bloating; most often diabetic, post-surgical or idiopathic. Management combines dietary measures, prokinetics and antiemetics.

Red flags

  • Severe dehydration or electrolyte disturbance
  • Rapid weight loss / inability to maintain nutrition
  • Haematemesis or features of obstruction
  • QT prolongation on prokinetics

Assessment

Differential diagnosis

  • Mechanical gastric outlet obstruction
  • Functional dyspepsia
  • Cyclic vomiting / cannabinoid hyperemesis
  • Rumination syndrome
  • Medication effect (GLP-1 agonists, opioids)
  • Superior mesenteric artery syndrome

Investigations

  • Gastric emptying scintigraphy (4-hour solid-phase; gold standard)
  • Upper endoscopy to exclude mechanical obstruction
  • HbA1c and glucose optimisation review
  • U&E, nutritional markers, weight trend
  • Review culprit drugs (opioids, anticholinergics, GLP-1 agonists)

Management

  • Confirm delayed emptying and exclude mechanical obstruction with endoscopy
  • Optimise glycaemic control in diabetics (hyperglycaemia slows emptying)
  • Stop or reduce medications that delay emptying (opioids, anticholinergics, GLP-1 analogues)
  • Dietary measures: small frequent low-fat, low-fibre meals; more liquid calories if severe
  • Start a prokinetic — metoclopramide first-line, time-limited to minimise tardive dyskinesia risk
  • Add antiemetics for symptom control (ondansetron, prochlorperazine)
  • Consider domperidone (ECG/QT check) or erythromycin for refractory cases
  • Ensure hydration and nutritional support; involve dietitian
  • For refractory disease consider gastric electrical stimulation, G-POEM, or jejunal feeding at specialist centre
  • Monitor weight, electrolytes and symptom scores
  • Screen for and treat overlapping anxiety/depression affecting symptom burden

Drugs & doses

Metoclopramide 10 mg PO three times daily (limit ≤12 weeks)
Domperidone 10 mg PO three times daily (QT/ECG caution)
Erythromycin 125–250 mg PO three times daily (short-term, tachyphylaxis)
Ondansetron 4–8 mg PO/IV up to three times daily
Prochlorperazine 5–10 mg PO three times daily

Disposition

Outpatient GI and dietitian management; tertiary referral for refractory disease and feeding/neurostimulation options.

Complications & pitfalls

  • Malnutrition and weight loss
  • Dehydration and electrolyte disturbance
  • Mallory-Weiss tear / bezoar
  • Erratic glycaemic control
  • Tardive dyskinesia from prolonged metoclopramide

Exam pearls

  • Exclude GLP-1 receptor agonists and opioids as reversible causes before labelling idiopathic
  • Limit metoclopramide to short courses because of tardive dyskinesia risk
  • Tight glycaemic control itself improves gastric emptying in diabetics
  • Liquid-calorie nutrition is tolerated better than solids in severe disease

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.